Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.44−0.06 (-4.00%)
Close on Nov 18, 2026Market cap $31.73MP/E –Yield –
Nexalin Technology gross margin
Gross margin is gross profit as a percentage of revenue.
Nexalin Technology's gross margin for the twelve months ending Jun 30, 2026 was 86.2%. For fiscal 2025 it was 79.7%, against 78.3% the year before. The highest annual figure on record is 85.1% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 79.7% | +1.3 |
| FY2024 | Dec 31, 2024 | 78.3% | +1.5 |
| FY2023 | Dec 31, 2023 | 76.8% | +4.3 |
| FY2022 | Dec 31, 2022 | 72.5% | −12.6 |
| FY2021 | Dec 31, 2021 | 85.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 73.2% | +5.5 |
| Q1 FY2026 | Mar 31, 2026 | 87.8% | +20.9 |
| Q4 FY2025 | Dec 31, 2025 | 87.8% | +15.3 |
| Q3 FY2025 | Sep 30, 2025 | 78.2% | +13.5 |
| Q2 FY2025 | Jun 30, 2025 | 67.6% | −5.4 |
| Q1 FY2025 | Mar 31, 2025 | 66.9% | −21.4 |
| Q4 FY2024 | Dec 31, 2024 | 72.4% | −1.2 |
| Q3 FY2024 | Sep 30, 2024 | 64.8% | −12.0 |
| Q2 FY2024 | Jun 30, 2024 | 73.0% | −9.1 |
| Q1 FY2024 | Mar 31, 2024 | 88.4% | +22.7 |
| Q2 FY2023 | Jun 30, 2023 | 73.6% | +3.3 |
| Q1 FY2023 | Mar 31, 2023 | 76.7% | −9.0 |
| Q4 FY2022 | Dec 31, 2022 | 82.1% | −22.1 |
| Q3 FY2022 | Sep 30, 2022 | 65.7% | −17.7 |
| Q2 FY2022 | Jun 30, 2022 | 70.3% | – |
| Q1 FY2022 | Mar 31, 2022 | 85.8% | – |
| Q4 FY2021 | Dec 31, 2021 | 104.2% | – |
| Q3 FY2021 | Sep 30, 2021 | 83.4% | – |
See a number that looks wrong?